For instance, MCMVgp100KGP vaccine targeting melanoma gp100 antigen was generated in a laboratory utilizing recombinant murine CMV as a vaccine carrier, gp100 specific CD8+ T cells were activated by the vaccine to effectively protect mice against highly aggressive lung B16-F10 melanoma 153. This evidence concerns the gene PMEL and melanoma.